. A German pharmacist, Dr. Willmar Schwabe (1839 – 1917), one of the pioneers in homoeopathy, was so dissatisfied with this situation that he had the motive action to set quality standards for the production of homoeopathic medicines. His work and commitment have been a binding legacy for Schwabe Group up to the present day. In 1866, two years after his qualification as a pharmacist, he founded his own company “Homöopatische Centralofficin Dr. Willmar Schwabe” (Central Homoeopathic Dispensary Dr. Willmar Schwabe).

In 1866 he founded a publishing house specialising in literature for both the medical profession and the public.
In 1872, he produced the standard work for homoeopathic pharmaceuticals – the “Pharmacopoea Homoeopathica Polyglottica”, which gave minutely detailed instructions on the production of homoeopathic medicines. It was another milestone in homoeopathy. Soon, Schwabe´s work gained world-wide recognition and was translated into many languages. In 1934, a new edition was published as the official “Deutsches Homöopatisches Arzneibuch” (German Homoeopathic Pharmacopoeia), which is now incorporated into the homoeopathic section of the official German Pharmacopoeia.
Through out his life, the main aim of Dr. Willmar Schwabe was to provide high quality homoeopathic medicines by standardising the industrial production with modern analytical technologies as well as strictly adhering to the rules laid down by Dr. Samuel Hahnemann, the founder of homoeopathy. To quote Dr. Willmar Schwabe: “I have founded an institution of my own which examines every homoeopathic remedy for genuineness and purity and which sets standards for its quantity, the content, effectiveness and characteristics of the substances”.
With each following generation, Schwabe group continued to grow. The values of the founder, reliability, innovation, quality and responsibility, still guide the company’s evolution. These are the principles on which our success is based.

Today, the fourth generation still continues the family traditions of the company.